Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/FL/Miami
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Miami, FL

Studies commonly pay $75 to $4,500 per completed study

1,911 clinical trials are currently recruiting participants within 30 miles of Miami. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

1,911studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Miami right now

Top 25 of 1,911 recruiting studies, sorted by proximity — each links to its official registry page

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

Multiple Myeloma Phase 3 Interventional 893 participants sought
University of Miami Hospital and Clinics — Miami, Florida (1.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT05020236)

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

High Grade Glioma, Diffuse Intrinsic Pontine Glioma Phase 2 Interventional 120 participants sought
Nicklaus Children's Hospital — Miami, Florida (1.2 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05096481)

A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

Advanced Solid Tumors Phase 1, Phase 2 Interventional 83 participants sought
Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida (5.0 mi) · Sponsor: Jiangsu HengRui Medicine Co., Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT05277168)

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia Phase 1 Interventional 40 participants sought
University of Miami - Miller School of Medicine — Coral Gables, Florida (5.6 mi) · Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
See eligibility & contact on ClinicalTrials.gov (NCT05500807)

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Healthy Volunteers, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Phase 1, Phase 2 Interventional 172 participants sought
Genoma Research Group, Inc — Miami, Florida (1.2 mi) · Sponsor: Regeneron Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT05648214)

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma Phase 1 Interventional 168 participants sought
BRCR Global — Tamarac, Florida (29.7 mi) · Sponsor: OncoNano Medicine, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06022029)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
University of Miami Miller School of Medicine-Sylvester Cancer Center — Miami, Florida (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy

Chronic Graft-versus-host Disease (cGVHD) Phase 2 Interventional 120 participants sought
Univ of Miami - Sylvester Comprehensive Cancer Center — Miami, Florida (1.2 mi) · Sponsor: H. Lee Moffitt Cancer Center and Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT06660355)

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Lymphoma, Large B-Cell, Diffuse Phase 2 Interventional 594 participants sought
Mount Sinai Braman Comprehensive Cancer Center ( Site 0140) — Miami Beach, Florida (5.0 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06890884)

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Lymphoma, Non-Hodgkin, Multiple Myeloma Phase 2 Interventional 4,200 participants sought
University of Miami Sylvester Comprehensive Cancer Center — Miami, Florida (1.2 mi) · Sponsor: American Society of Clinical Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02693535)

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Adamantinous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Phase 2 Interventional 38 participants sought
Nicklaus Children's Hospital — Miami, Florida (1.2 mi) · Sponsor: Nationwide Children's Hospital
See eligibility & contact on ClinicalTrials.gov (NCT05286788)

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine

Migraine Phase 2 Interventional 488 participants sought
Flourish Research - Miami, LLC dba Flourish Research — Miami, Florida (1.2 mi) · Sponsor: AbbVie
See eligibility & contact on ClinicalTrials.gov (NCT06602479)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Miami, Florida (1.2 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Miami Beach, Florida (5.0 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

Urothelial Cancer, Bladder Cancer Phase 2, Phase 3 Interventional 630 participants sought
Research Site — Tamarac, Florida (29.7 mi) · Sponsor: Daiichi Sankyo
See eligibility & contact on ClinicalTrials.gov (NCT07129993)

Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

Non-segmental Vitiligo Phase 2 Interventional 45 participants sought
Skin Care Research, LLC — Hollywood, Florida (16.1 mi) · Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
See eligibility & contact on ClinicalTrials.gov (NCT07223229)

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Neovascular Age-related Macular Degeneration Phase 4 Interventional 188 participants sought
Ft Lauderdale Eye Institute — Plantation, Florida (24.2 mi) · Sponsor: Genentech, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT04853251)

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Large B-cell Lymphoma Phase 2 Interventional 250 participants sought
Miami Cancer Institute at Baptist Health, Inc. — Miami, Florida (1.2 mi) · Sponsor: Allogene Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06500273)

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes N/A Observational 200 participants sought
University of Miami — Miami, Florida (1.2 mi) · Sponsor: Jaeb Center for Health Research
See eligibility & contact on ClinicalTrials.gov (NCT06837181)

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Phase 4 Interventional 787 participants sought
Sylvester Comprehensive Cancer Center — Miami, Florida (1.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06876649)

Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.

Amyotrophic Lateral Sclerosis (ALS), Primary Lateral Sclerosis (PLS) N/A Interventional 10 participants sought
Nova Southeastern University, David and Cathy Husman Neuroscience Institute — Davie, Florida (19.3 mi) · Sponsor: Nova Southeastern University
See eligibility & contact on ClinicalTrials.gov (NCT07187388)

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Non-Small Cell Lung Cancer (NSCLC) Phase 3 Interventional 750 participants sought
BRP- Hialeah Hospital — Hialeah, Florida (6.6 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07361510)

Improving Postoperative Recovery: A Study of Multimodal Perineal Analgesia Protocol (MPAP) After Vaginal Surgery

Perineal Injury, Pain Vulva Phase 4 Interventional 70 participants sought
University of Miami Hospitals and Clinics — Miami, Florida (1.2 mi) · Sponsor: University of Miami
See eligibility & contact on ClinicalTrials.gov (NCT07401134)
Actively enrolling

Studies you may be able to join near Miami

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for severe chronic itching

Enrolling adults aged 18 to 90 who have had chronic itching for six months or longer. Not open to itching caused by atopic dermatitis, psoriasis, chronic kidney disease, notalgia paresthetica or medication, nor to people with an autoimmune condition such as lupus, Crohn's disease, ulcerative colitis or rheumatoid arthritis.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research studies for chronic kidney disease

This research platform is enrolling Black and African American adults in eligible areas who have been diagnosed with chronic kidney disease. Compensation may be available. The study team confirms eligibility before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Miami

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

University of Miami Clinical Research Building

★ 4.4
1120 NW 14th St, Miami, FL 33136
(305) 243-2000
"Place is impressive-except for the doctor that I saw."
— No NAME, 4★

Flourish Research - Miami

★ 4.5
2128 W Flagler St 1st Floor, Miami, FL 33135
(305) 920-2020
"They told me at the beginning a payment and when I finished the consultation they took around 90$ off my payment because they said it was to pay the …"
— Honestly, my experience, 2★

Syneos Health Miami

★ 4.4
1951 NW 7th Ave #180, Miami, FL 33136
(305) 351-9955
"Tuve una excelente experiencia en Syneos Health Miami gracias a la señora Mary. Fue muy profesional, amable y atenta durante todo el proceso. Su trat…"
— Emely Glez, 5★

South Florida Research Center Inc

★ 5.0
2140 W Flagler St #112, Miami, FL 33135
(305) 456-3236
"Awesome staff! I was in and out quickly! 10/10 recommend!"
— Lizandra Perdomo, 5★

Columbus Clinical Services, LLC

★ 4.7
110 NW 27th Ave, Miami, FL 33125
(305) 631-6991
"Excellent service, I felt wonderfully comfortable in every way. The staff was very friendly, and you felt a sense of personalized attention.<br>I fel…"
— Martha Zuluaga, 5★

Don Soffer Clinical Research Center

★ 4.8
1120 NW 14th St, Miami, FL 33136
(305) 243-2000
"Modern, organized, and friendly medical center. Impressive."
— Richard Clemmer, 5★

Nova Research Institute LLC

★ 5.0
285 NW 27th Ave #14, Miami, FL 33125
(305) 456-5531
"Nova Research is a pillar of medical research. Their professionalism, scientific rigor, and human warmth ensure that every study feels in the best ha…"
— casa oro, 5★

Vitaly Clinical Research

★ 4.8
3401 NW 7th St, Miami, FL 33125
(305) 201-3000
"Was time and got my son out study from giving him medication this the no good for person Health stay alway from them also alway text me brothering"
— Magaly Suarez, 1★

SouthCoast Research Center

1011 Sunnybrook Rd Ste 901, Miami, FL 33136
(786) 343-6937

Clinical trials in Miami: what's recruiting

The Miami area currently has 1,911 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Miami, the most active research areas are:

  • Cancer & Oncology14 studies
  • Heart & Vascular3 studies
  • Diabetes & Metabolism2 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Miami, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Miami

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Miami participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Miami pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Miami, FL?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Miami?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Miami?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Miami.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Miami typically complete one or two studies per year.

Paid clinical trials near Miami

Other metros within reach

Hialeah, FL1,934 Hollywood, FL1,980 Pembroke Pines, FL1,980 Fort Lauderdale, FL1,987 Port St. Lucie, FL105 Bonita Springs, FL296 Cape Coral, FL246 Palm Bay, FL72

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Miami Severe Chronic Pruritus in Miami Chronic Kidney Disease (HealthMatch) in Miami Bladder Issues Due To Spinal Cord Injury in Miami All conditions

More of FL

Fort Lauderdale1,987 Pembroke Pines1,980 Hollywood1,980 Hialeah1,934 St. Petersburg1,353 Tampa1,335 Deltona953 Orlando942 Kissimmee927 Jacksonville916 Gainesville538

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts